RECRUITING

Cannabis Effects as a Function of Sex (CanSex)

Talk to us

Conditions

PainAbuse, DrugCannabisTHC

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women

Official Title

Sex-dependent Effects of Cannabis: Assessing Analgesic, Abuse-related and Pharmacokinetic Differences Between Men and Women

Quick Facts

Study Start:2021-07-08
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04385082

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or non-pregnant female aged 21-55 years
  2. * Report use of cannabis an average of 1-7 days per week
  3. * Not currently seeking treatment for their cannabis use
  4. * Urine test positive for recent cannabis use for heavy users
  5. * No reported adverse effects with cannabis smoking in light users
  6. * Have a Body Mass Index from 18.5 - 34kg/m2.
  7. * Able to perform all study procedures
  8. * FEMALES: Currently practicing a non-hormonal effective form of birth control
  9. * FEMALES: Must be regularly cycling
  1. * Meeting DSM-V criteria for any substance use disorder other than nicotine, caffeine, or cannabis use disorder
  2. * Report using other illicit drugs in the prior 4 weeks
  3. * History or current evidence of severe psychiatric illness or medical condition judged by the study physician and PI to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent.
  4. * Current use of medical cannabis, prescription analgesics, or any medications that may affect study outcomes
  5. * Current pain
  6. * Insensitivity to the cold water stimulus of the Cold Pressor Test
  7. * FEMALES: using a hormonal contraceptive

Contacts and Locations

Study Contact

Ziva Cooper, PhD
CONTACT
310-206-9942
zcooper@mednet.ucla.edu
Vincent Acebo
CONTACT
310-983-3417
vacebo@mednet.ucla.edu

Principal Investigator

Ziva Cooper, PhD
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles

Study Locations (Sites)

University of California, Los Angeles
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Ziva Cooper, PhD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-08
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2021-07-08
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Pain
  • Cannabis
  • THC

Additional Relevant MeSH Terms

  • Pain
  • Abuse, Drug